Date published: 2026-1-21

1-800-457-3801

SCBT Portrait Logo
Seach Input

Synaptotagmin V Inhibitors

Synaptotagmin V (SytV) is a synaptic vesicle protein that plays a crucial role in neurotransmitter release at neuronal synapses. It is primarily involved in calcium-dependent exocytosis, where it acts as a calcium sensor to trigger vesicle fusion with the plasma membrane, leading to neurotransmitter release into the synaptic cleft. SytV contains tandem C2 domains that bind calcium ions, allowing it to undergo conformational changes upon calcium binding, thereby facilitating membrane fusion. Additionally, SytV has been implicated in regulating synaptic vesicle trafficking and recycling, further highlighting its significance in neurotransmission.

Inhibition of Synaptotagmin V can occur through various mechanisms aimed at disrupting its calcium-sensing and membrane fusion functions. One potential strategy involves targeting the calcium-binding sites within its C2 domains, thereby preventing its conformational changes and subsequent vesicle fusion. Additionally, interference with the protein-protein interactions essential for SytV's recruitment to the synaptic vesicle membrane or its interaction with other synaptic proteins could hinder its function. Another approach may involve modulating downstream signaling pathways associated with SytV-mediated neurotransmitter release, such as protein kinases or phosphatases that regulate synaptic vesicle exocytosis.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

BAPTA, Free Acid

85233-19-8sc-201508
sc-201508A
100 mg
500 mg
$68.00
$267.00
10
(1)

BAPTA is a calcium chelator that can buffer intracellular calcium, thus potentially inhibiting the calcium-dependent binding of Synaptotagmin V to phospholipids and SNARE proteins, which is crucial for vesicle fusion.

EGTA

67-42-5sc-3593
sc-3593A
sc-3593B
sc-3593C
sc-3593D
1 g
10 g
100 g
250 g
1 kg
$21.00
$65.00
$120.00
$251.00
$815.00
23
(1)

EGTA is another calcium chelator with a slower calcium-binding kinetics than BAPTA. It can selectively buffer extracellular calcium, affecting the activation of Synaptotagmin V.

ω-Agatoxin IVA

145017-83-0sc-302015
100 µg
$463.00
(0)

ω-Agatoxin IVA is a P/Q-type calcium channel blocker, which can also decrease calcium influx, indirectly inhibiting Synaptotagmin V activity.

ML-9

105637-50-1sc-200519
sc-200519A
sc-200519B
sc-200519C
10 mg
50 mg
100 mg
250 mg
$112.00
$449.00
$673.00
$1224.00
2
(1)

ML-9 is a kinase inhibitor that can inhibit myosin light chain kinase (MLCK), potentially altering cytoskeletal dynamics and indirectly affecting Synaptotagmin V's role in vesicle movement.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

Dynasore is a small molecule that inhibits dynamin, a GTPase involved in vesicle scission. This can indirectly affect Synaptotagmin V's function in vesicle recycling.

Tetracaine

94-24-6sc-255645
sc-255645A
sc-255645B
sc-255645C
sc-255645D
sc-255645E
5 g
25 g
100 g
500 g
1 kg
5 kg
$66.00
$309.00
$500.00
$1000.00
$1503.00
$5000.00
(0)

Tetracaine is a local anesthetic that blocks voltage-gated sodium channels, which can indirectly inhibit action potential propagation and thus Synaptotagmin V-mediated exocytosis.

Methyllycaconitine citrate

112825-05-5sc-253043
sc-253043A
5 mg
25 mg
$119.00
$406.00
2
(1)

This compound is an antagonist of the alpha-7 nicotinic acetylcholine receptor, which upon inhibition, can modulate calcium signaling and indirectly affect Synaptotagmin V activity.